Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. - Wikidata - awgldk - TriplyDB

Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia.

Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia.

http://www.wikidata.org/entity/Q37588345

about

Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells Targeting the duality of cancer.In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example

P2860

Q40985734-C3515853-0CD4-461F-93A7-8DCC309220DE Q52539731-118B8B5B-19F4-4DA4-AB6C-5F6451439061 Q58772664-8983E1B9-BA4C-4A8F-856F-15C31725F89F

P2860

Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia.

http://www.wikidata.org/entity/Q37588345

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cooperation of imipramine blue ...... inst chronic myeloid leukemia.

@en

Cooperation of imipramine blue ...... inst chronic myeloid leukemia.

@nl

type

label

Cooperation of imipramine blue ...... inst chronic myeloid leukemia.

@en

Cooperation of imipramine blue ...... inst chronic myeloid leukemia.

@nl

prefLabel

Cooperation of imipramine blue ...... inst chronic myeloid leukemia.

@en

Cooperation of imipramine blue ...... inst chronic myeloid leukemia.

@nl

P1433

Q37588345-332CE321-39A3-401D-88E7-1D72E8ADB232

P1476

Q37588345-3E6099C3-8774-4B3C-80BD-CFE40EA37EB5

P2093

Q37588345-282CA8FB-4A1E-4E0A-9FFD-862FB3907F28

Q37588345-2BF8A967-CC8D-45B2-9B22-E210BCB71F09

Q37588345-5E07C113-5AB4-417B-96FE-B11653818031

Q37588345-5F2926A5-648A-49C2-BDC2-2EA4DBE0CA64

Q37588345-7EB1BDD7-4538-4D17-97D7-BC6AE777033A

Q37588345-BDC3117D-029B-425A-B3C9-6C0627CDAA7B

Q37588345-C23423A2-178B-49ED-8DF6-D8536505E283

Q37588345-CF21879A-EF5A-4164-80BD-81829B7DDA82

Q37588345-D11D0310-DD0C-4BC4-BF92-9D03A4C825E7

Q37588345-F154E348-9455-4CE3-9059-06098DE5149E

P2860

Q37588345-08C555A5-22FE-40AF-878E-0EA19AB59AEE

Q37588345-121B1341-DA79-4599-9659-B644BEB7261D

Q37588345-1A8BE403-D38C-4E1A-8262-58F0DA0F26B9

Q37588345-215DA655-94EF-470D-B5B7-09CB03C26C54

Q37588345-2ED9A059-B142-4429-B810-2B91095FBE21

Q37588345-3A58941C-5DB6-4C84-9A25-FCC7AB320EB9

Q37588345-4568E262-620F-4DED-BC6F-B5BDB08E3382

Q37588345-5466A80B-2125-48F6-8E9A-D055E7D8639E

Q37588345-5C4BDE1B-42F0-4B3C-9F2F-379A0995AAA7

Q37588345-66027169-9344-4A8B-9290-7ECD7BBEB58D

P304

Q37588345-1194695D-E0AC-4557-9104-93B253B7DEF3

P31

Q37588345-5BB81571-018F-4A68-B21E-467A662426D5

P356

Q37588345-A493F548-CD8C-4A50-9D22-40B828C6CB4B

P407

Q37588345-C8FD750F-A0F2-437C-B6B3-48AF3C949CD8

P433

Q37588345-39BC4AE4-942A-4A45-9C70-2428E19215B1

P478

Q37588345-C10B0CAC-67D0-425A-BCFD-873838FEE503

P50

Q37588345-80B78F05-107A-408E-AF79-B9C49D390E70

P577

Q37588345-E9AF6B6B-AABB-4F65-A644-CA3E30E028C4

P698

Q37588345-A90C3B0C-1D8D-4431-A027-7FC1C5076774

P921

Q37588345-BE6C36D2-FE4F-43AA-9435-099BC21FC39E

Q37588345-F79847EB-F17C-412F-966A-038717CA3351

P932

Q37588345-CEED3CB6-E448-41EF-806A-A2DBDFAE0314

P356

ONCOTARGET.10541

P1433

P1476

Cooperation of imipramine blue ...... ainst chronic myeloid leukemia

@en

P2093

Bharat Aggarwal

http://www.w3.org/2001/XMLSchema#string

Danilo Perrotti

http://www.w3.org/2001/XMLSchema#string

David A Frank

http://www.w3.org/2001/XMLSchema#string

Giovannino Silvestri

http://www.w3.org/2001/XMLSchema#string

Heather G Jørgensen

http://www.w3.org/2001/XMLSchema#string

Jack L Arbiser

http://www.w3.org/2001/XMLSchema#string

Michael Y Bonner

http://www.w3.org/2001/XMLSchema#string

Samuel Berhan

http://www.w3.org/2001/XMLSchema#string

Suhu Liu

http://www.w3.org/2001/XMLSchema#string

Tessa L Holyoake

http://www.w3.org/2001/XMLSchema#string

P2860

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

Identifying new small molecule anti-invasive compounds for glioma treatment

Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

Cross talk between mitochondria and NADPH oxidases

Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis

A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia.

Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate

Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment

P304

51651-51664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10541

http://www.w3.org/2001/XMLSchema#string

P407

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Kamilla Laidlaw

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27438151

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

5239504

http://www.w3.org/2001/XMLSchema#string